Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15,...
Clinical Trial
REPEAT — Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
Includes $36 million line of credit and potential $14 million private placement WARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) --...
Hemostemix’s Social Media for Investors and Florida’s No-Option Patients
Calgary, Alberta--(Newsfile Corp. - August 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...
DEA Unconstitutional Marijuana Playbook: How the DEA Is Repeating the DOL’s Mistakes Against MMJ BioPharma
"Two Federal Agencies, One Unconstitutional Playbook, all While Agency Overreach Crushes a 125 year old Family Farm and Paralyzes a...
BioNxt Fast-Tracks U.S. Patent for MS Drug and Secures Broad Platform IP Covering Autoimmune Neurology Pipeline
VANCOUVER, BC / ACCESS Newswire / August 20, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a...
ANGLE Announces Collaboration with Myriad Genetics
Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing tissue-based diagnostic test...
Biolabs International’s New App Cuts Clinic Visits, Expands Testing Access
Biolabs' CONNECTED DIAGNOSTICS App and decentralized clinical trial platform integrates rapid diagnostic testing, artificial intelligence, and telehealth, all accessible from a smartphone...
Patientory’s AI-Enterprise Analytics Dashboard Now Available on Oracle Healthcare Marketplace
Patientory's Enterprise Analytics Dashboard is now integrated with Oracle Health technologies to support proactive care, clinical trial recruitment, and strategic...
Real World Evidence Solutions Market worth $10.83 billion by 2030 with 14.8% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 19, 2025 /PRNewswire/ -- The global Real World Evidence Solutions Market, valued at US$4.74 billion in 2024,...
Qaelon Medical Announces Formation of Scientific Advisory Board and Appoints Dr. Andrew Storm
STRASBOURG, France, Aug. 19, 2025 /PRNewswire/ -- Qaelon Medical, a pioneer in real-time surgical leak detection and advanced insufflation technology,...
LabConnect Launches LabConnector™ to Streamline Lab Data Integration
New service ensures faster, more accurate data delivery to clients JOHNSON CITY, Tenn., Aug. 19, 2025 /PRNewswire/ -- LabConnect, LLC,...
University Hospitals Launches HealthSnap-Powered RPM for Uncontrolled Hypertension Care
CLEVELAND and MIAMI, Aug. 19, 2025 /PRNewswire/ -- HealthSnap, a leading virtual care management company, announced today that University Hospitals (UH),...
New US$ 1 Million Prize Competition Aims to Revolutionize Alzheimer’s Research by Leveraging Agentic AI Systems
SEATTLE, Aug. 19, 2025 /PRNewswire/ -- The Alzheimer's Disease Data Initiative (AD Data Initiative) today launched the Alzheimer's Insights AI Prize |...
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4...
Ensysce Biosciences’ Geoff Birkett to Chair the Fierce New Product Planning Summit 2025
~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed,...
Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices
New agreement brings innovative shock wave, tPEMF therapy, monitoring, and bleeding control solutions to more than 2,200 member clinics nationwide...
Kyowa Kirin Premiers New CTCL Staging Tool for Healthcare Providers
First-of-its kind tool to guide HCPs on what to consider when staging patients with Mycosis Fungoides and Sézary SyndromePRINCETON, N.J.,...
60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
90-day trial measuring change in general fatigue in chronic babesiosis patientsEnrollment expected to commence Q4 2025 and to be completed...
Cannabix Technologies delivers Marijuana Breath Test Hardware to Omega Laboratories Inc.
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the...